trial · primary record
Apremilast XR
Psoriasis
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 114 |
| Primary completion | 2027-01-10 |
| Primary endpoint | Area Under the Plasma Concentration-time Curve (AUC) from Time Zero extrapolated to Infinity (AUCinf) of Apremilast. |
| Registry ID | NCT07908641 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:52.790Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908641
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.